Clinical Trial Update: PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT [Phase 2]

View source ↗

Summary

A Phase 2 trial at Johns Hopkins is evaluating adding PSMA617 to standard external beam radiotherapy and androgen deprivation therapy for high-risk localized pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PSMA617 (PSMA617)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: High-Risk Localized Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING